← Eichor
Study identifier: NCT07503236 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Early Feasibility Study (EFS) of the Nyra Cardiac Leaflet Enhancer (CARLEN) System

Condition: Mitral Regurgitation Functional  ·  Sponsor: Nyra Medical, Inc.

PhaseNA
Planned participants30
Who can joinAll sexes, 21 Years to no upper limit
Healthy volunteersNo

About this study

Safety and performance evaluation of the CARLEN System in patients with functional mitral valve regurgitation.

This description comes directly from the study's public registry record.

Talk to the study team

Jennifer Mischke, VP of Regulatory and Clinical  ·  888 397 8046  ·  jmischke@nyra-medical.com

Always discuss trial participation with your own doctor first.

Locations (3)

University of California, DavisSacramento, California, United StatesRecruiting
University of MichiganAnn Arbor, Michigan, United StatesRecruiting
The Christ HospitalCincinnati, Ohio, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07503236